| Gene symbol | CD7 | Synonyms | GP40, LEU-9, TP41, Tp40 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q25.3 | dbXrefs | |
| Description | CD7 molecule | ||||
| GTO ID | GTC2403 |
| Trial ID | NCT04480788 |
| Disease | Peripheral T-Cell Lymphoma | Angioimmunoblastic T-Cell Lymphoma | Anaplastic Large Cell Lymphoma | Nasal Type Extranodal NK/T-Cell Lymphoma |
| Altered gene | CD7 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD7 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | CD7-CART in the Treatment of r / r CD7 Positive Hemolymph System Malignancies on Increasing Dose and Open Label Study |
| Year | 2020 |
| Country | China |
| Company sponsor | PersonGen BioTherapeutics (Suzhou) Co., Ltd. |
| Other ID(s) | PG-CART-07-001 |
| Cohort 1 | |||||||||
|
|||||||||